Last year, America’s pharmaceutical companies invested nearly $50 billion in research for new drugs, to treat diseases from hepatitis to depression. On this edition of The Moral Is, commentator Kaye Bonner Cummings says that despite those massive investments, new research is calling into question our reliance, or perhaps our over reliance, on prescription medication.
The views expressed on The Moral Is are those of the author and do not necessarily represent the views of Valley Public Radio.